The vital role of constitutive GPCR activity in the mesolimbic dopamine system

Constitutive  -Opioid Receptor Activity Leads to Long-Term Endogenous Analgesia and Dependence

(2013) G. Corder et al.   SCIENCE

GHS-R1a constitutive activity and its physiological relevance

(2013) Yves Mear et al.   Frontiers in Neuroscience

Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance

(2012) Joseph Tam et al.   Cell Metabolism

Morphine Withdrawal Enhances Constitutive  -Opioid Receptor Activity in the Ventral Tegmental Area

(2012) F. J. Meye et al.   JOURNAL OF NEUROSCIENCE

Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity

(2012) F J Meye et al.   MOLECULAR PSYCHIATRY

Dopamine neurons modulate neural encoding and expression of depression-related behaviour

(2012) Kay M. Tye et al.   NATURE

An Anatomical Basis for Opponent Process Mechanisms of Opiate Withdrawal

(2011) A. K. Radke et al.   JOURNAL OF NEUROSCIENCE

Analgesic Tone Conferred by Constitutively Active Mu Opioid Receptors in Mice Lacking β-Arrestin 2

(2011) Hoa Lam et al.   Molecular Pain

The Central Cannabinoid CB1 Receptor Is Required for Diet-Induced Obesity and Rimonabant's Antiobesity Effects in Mice

(2011) Zhen Pang et al.   Obesity

Neuronal circuits underlying acute morphine action on dopamine neurons

(2011) M. Jalabert et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Striatal Balancing Act in Drug Addiction: Distinct Roles of Direct and Indirect Pathway Medium Spiny Neurons

(2011) Mary Kay Lobo et al.   Frontiers in Neuroanatomy

The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors

(2011) Ana Luisa Terzian et al.   Frontiers in Behavioral Neuroscience

The Peptide Hemopressin Acts through CB1 Cannabinoid Receptors to Reduce Food Intake in Rats and Mice

(2010) G. T. Dodd et al.   JOURNAL OF NEUROSCIENCE

Opioid-Induced GABA Potentiation after Chronic Morphine Attenuates the Rewarding Effects of Opioids in the Ventral Tegmental Area

(2010) A. Madhavan et al.   JOURNAL OF NEUROSCIENCE

Constitutive Activity of Serotonin2C Receptors at G Protein-Independent Signaling: Modulation by RNA Editing and Antidepressants

(2010) M. Labasque et al.   MOLECULAR PHARMACOLOGY

Depression-like phenotype following chronic CB1 receptor antagonism

(2010) Chad E. Beyer et al.   NEUROBIOLOGY OF DISEASE

Functional relevance of serotonin 2C receptor mRNA editing in antidepressant- and anxiety-like behaviors

(2010) Cedric Mombereau et al.   NEUROPHARMACOLOGY

Effect of Acute Ethanol Administration on the Release of Opioid Peptides From the Midbrain Including the Ventral Tegmental Area

(2009) Samuel Jarjour et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142

(2009) K.S. Sink et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Identification of a novel “almost neutral” μ-opioid receptor antagonist in CHO cells expressing the cloned human μ-opioid receptor

(2009) Elliott J. Sally et al.   SYNAPSE

Constitutive Activity of the Cannabinoid CB1 Receptor Regulates the Function of Co-expressed Mu Opioid Receptors

(2008) Meritxell Canals et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors

(2008) V.J. Aloyo et al.   PHARMACOLOGY & THERAPEUTICS

Antipsychotic drug action: antagonism, inverse agonism or partial agonism

(2008) P STRANGE   TRENDS IN PHARMACOLOGICAL SCIENCES